Microbot Medical Inc. (MBOT) Trading 5.4% Higher

Microbot Medical Inc. (NASDAQ:MBOT)’s share price traded up 5.4% during trading on Thursday . The company traded as high as $1.17 and last traded at $1.17. 869,238 shares changed hands during mid-day trading, a decline of 44% from the average session volume of 1,544,750 shares. The stock had previously closed at $1.11.

The firm’s market cap is $48.00 million. The company’s 50-day moving average price is $1.22 and its 200 day moving average price is $2.14.

Microbot Medical (NASDAQ:MBOT) last posted its earnings results on Monday, August 14th. The biotechnology company reported ($0.04) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.48) by $0.44. On average, analysts forecast that Microbot Medical Inc. will post ($25.02) earnings per share for the current year.

In other Microbot Medical news, Director Moshe Shoham sold 33,700 shares of the business’s stock in a transaction that occurred on Monday, October 9th. The shares were sold at an average price of $1.50, for a total value of $50,550.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Yoseph Bornstein sold 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 24th. The stock was sold at an average price of $1.14, for a total transaction of $57,000.00. The disclosure for this sale can be found here. Insiders sold 424,310 shares of company stock valued at $520,396 over the last three months. Insiders own 31.83% of the company’s stock.

An institutional investor recently raised its position in Microbot Medical stock. Vanguard Group Inc. grew its holdings in Microbot Medical Inc. (NASDAQ:MBOT) by 252.2% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 159,992 shares of the biotechnology company’s stock after acquiring an additional 114,561 shares during the period. Vanguard Group Inc. owned 0.43% of Microbot Medical worth $228,000 as of its most recent SEC filing. 4.66% of the stock is owned by institutional investors.

WARNING: “Microbot Medical Inc. (MBOT) Trading 5.4% Higher” was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://transcriptdaily.com/2017/10/28/microbot-medical-inc-mbot-trading-5-4-higher.html.

Microbot Medical Company Profile

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Receive News & Ratings for Microbot Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply